Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
Authors
Keywords
-
Journal
SCIENCE
Volume 359, Issue 6383, Pages 1537-1542
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-03-30
DOI
10.1126/science.aao0505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
- (2016) Benjamin Izar et al. Pigment Cell & Melanoma Research
- Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated with Ipilimumab
- (2015) Y. Koguchi et al. CANCER RESEARCH
- A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection
- (2015) W. Deng et al. SCIENCE
- DNAM-1 Expression Marks an Alternative Program of NK Cell Maturation
- (2015) Ludovic Martinet et al. Cell Reports
- NKG2D Receptor and Its Ligands in Host Defense
- (2015) L. L. Lanier Cancer Immunology Research
- NKG2D Ligands in Tumor Immunity: Two Sides of a Coin
- (2015) Jinyu Zhang et al. Frontiers in Immunology
- Matrix metallopeptidase 2 (MMP2) media la eliminación de MHC class I polypeptide-related sequence A (MICA) en el cáncer de células renales
- (2014) F.Q. Yang et al. Actas Urologicas Espanolas
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Natural Killer Cells Are Essential for the Ability of BRAF Inhibitors to Control BRAFV600E-Mutant Metastatic Melanoma
- (2014) L. Ferrari de Andrade et al. CANCER RESEARCH
- MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques
- (2014) Shunji Ikeshita et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Human Tumor-Derived Exosomes Down-Modulate NKG2D Expression
- (2014) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Metalloproteinase ADAM17/TNF- -Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
- (2014) P. Boutet et al. JOURNAL OF IMMUNOLOGY
- Immunological Visibility: Posttranscriptional Regulation of Human NKG2D Ligands by the EGF Receptor Pathway
- (2014) P. Vantourout et al. Science Translational Medicine
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Regulation of Ligands for the NKG2D Activating Receptor
- (2013) David H. Raulet et al. Annual Review of Immunology
- Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17
- (2013) Guranda Chitadze et al. INTERNATIONAL JOURNAL OF CANCER
- Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis
- (2013) Gang Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding
- (2012) Leticia Huergo-Zapico et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- An six-amino acid motif in the α3 domain of MICA is the cancer therapeutic target to inhibit shedding
- (2009) Xuanjun Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now